NCT07751198

Brief Summary

This study evaluates the therapeutic effects of an oat-based porridge composite on fetomaternal outcomes and calcium/ vitamin D status among hypocalcemic antenatal women. Pregnant women diagnosed with hypocalcemia are evaluated to determine the efficacy of composite cereal supplementation alongside standard medical care. Blood samples collected at the 8th and 33rd weeks of gestation are analyzed to assess changes in serum calcium and Vitamin D concentrations. The study aims to evaluate whether oat-based porridge supplementation provides beneficial nutritional support for managing hypocalcemia during pregnancy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
192

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2025

Completed
25 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 14, 2025

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

July 25, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

August 7, 2026

Completed
Last Updated

August 7, 2026

Status Verified

August 1, 2026

Enrollment Period

6 months

First QC Date

July 25, 2026

Last Update Submit

August 5, 2026

Conditions

Keywords

HypocalcemiaFeto-maternal outcomesOat-based PorridgePregnancy nutrition,Calcium and vit D supplementationMaternal health

Outcome Measures

Primary Outcomes (1)

  • maternal serum Calcium and Vitamin D concentrations

    Evaluating using maternal blood samples to measure change in serum calcium levels in mg/dL And Vitamin D Levels in ng/mL from baseline to delivery.

    .Blood samples were collected at the 8th and 33rd weeks of gestation to assess changes in plasma calcium concentration through blood sampling, from enrollment to delivery .

Secondary Outcomes (1)

  • Incidence of Fetomaternal Complications

    Throughout Pregnancy upto delivery

Study Arms (2)

CONTROL GROUP

ACTIVE COMPARATOR

Participants receiving standard supplementation of calcium and vit.D

Dietary Supplement: Calcium & Vitamin D3 supplementation

EXPERIMENTAL GROUP

EXPERIMENTAL

Participants receiving standard supplementation of calcium and vit.D along with interventional Oat-Based Porridge

Dietary Supplement: Oat-Based porridgeDietary Supplement: Calcium & Vitamin D3 supplementation

Interventions

Oat-Based porridgeDIETARY_SUPPLEMENT

participants consumed Oat-based porridge daily as part of their diet during pregnancy alongside standard prenatal supplements

EXPERIMENTAL GROUP

standard prescribed by physicians

Also known as: prenatal dietary supplement
CONTROL GROUPEXPERIMENTAL GROUP

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Already taking vitamin D and calcium supplements as prescribed by the doctor.
  • Pregnant women in their 2nd and 3rd trimester.
  • Women between 20 to 40 years of age will be included.
  • Women with mild to moderate hypocalcemia (serum calcium less than 8-8.6 mg/dl) and 25(OH)D less than 30ng/ml will be entered to study.

You may not qualify if:

  • Women having twin pregnancy.
  • Gestational diabetes or diabetes before pregnancy.
  • Chronic hypertension.
  • Fetal anomaly, oligohydramnios or polyhydramnios, parathyroid disorders, hepatic or renal diseases, malnutrition.
  • Use of anti-convulsive and immunosuppressive drugs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saira Memorial Hospital Model Town Lahore Pakistan

Lahore, Punjab Province, 54700, Pakistan

Location

Related Publications (1)

  • Arshad, M. F., Elamin, A., Bennet, W., Choudhari, Y. K., & Balasubramanian, S. P. (2023). Abnormal Calcium Levels are Associated With Worse Maternal and Fetal Outcomes; Results From an Exploratory Study. The Journal of Clinical Endocrinology & Metabolism, 108(12), e1642-e1648. Association, W. M. (2013). World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Jama, 310(20), 2191-2194. Bako, B., El-Nafaty, A., Mshelia, D., Gali, R., Isa, B., & Dungus, M. (2021). Prevalence and risk factors of hypocalcemia among pregnant and non-pregnant women in Maiduguri, Nigeria: A cross-sectional study. Nigerian Journal of Clinical Practice, 24(1), 75-80. Binou, P., Yanni, A. E., & Karathanos, V. T. (2022). Physical properties, sensory acceptance, postprandial glycemic response, and satiety of cereal based foods enriched with legume flours: A review. Critical reviews in food science and nutrition, 62(10), 2722-2740. Chimonyo, V. G. P., Govender, L., Nyathi, M., Scheelbeek, P. F. D., Choruma, D. J., Mustafa, M., . . . Mabhaudhi, T. (2023). Can cereal-legume intercrop systems contribute to household nutrition in semi-arid environments: A systematic review and meta-analysis. Frontiers in nutrition, 10, 1060246. Ding, J.-J., Chiu, C.-F., Su, Y.-T., Lin, S.-H., Chiang, M.-C., Chu, S.-M., . . . Tseng, M.-H. (2025). Neonatal hypocalcemia caused by maternal hypercalcemia: clinical characteristics, etiology, treatment, and outcome. Pediatric Research, 1-9. Forsido, S. F., Duguma, H. T., Lema, T. B., Sturm, B., & Hensel, O. (2019). Nutritional and sensory quality of composite extruded complementary food. Food Science & Nutrition, 7(2), 882-889. Hofmeyr, G. J., Lawrie, T. A., Atallah, Á. N., & Torloni, M. R. (2018). Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane database of systematic reviews(10).

    BACKGROUND

MeSH Terms

Conditions

HypocalcemiaDisease

Interventions

Calcium

Condition Hierarchy (Ancestors)

Calcium Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesWater-Electrolyte ImbalancePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Metals, Alkaline EarthElementsInorganic ChemicalsMetalsBlood Coagulation FactorsBiological Factors

Study Officials

  • HABIB UR REHMAN, PhD

    NUR International University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants in the control group (T0) received routine prenatal supplementation prescribed by their physicians, including calcium (1000-1250 mg/day) and vitamin D3 (1000-1200 IU/day). The intervention group (Ta) received the same supplementation regimen plus one daily serving (240 g) of the selected oat-based porridge formulation , providing approximately 400 mg calcium, 590 mg phosphorus, and 175 mg magnesium per serving based on USDA FoodData Central values. Both groups were followed for six months. Participants with severe vitamin D deficiency (serum 25(OH)D \<20 ng/mL) received a loading dose of vitamin D3 (50,000 IU/week for 8 weeks) according to Endocrine Society recommendations, followed by reassessment of serum 25(OH)D levels and maintenance supplementation of 1000-1200 IU/day throughout pregnancy.
Sponsor Type
NETWORK
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 25, 2026

First Posted

August 7, 2026

Study Start

August 1, 2024

Primary Completion

January 20, 2025

Study Completion

February 14, 2025

Last Updated

August 7, 2026

Record last verified: 2026-08

Locations